| View |
|
DRHR-2058
|
Tretinoin
|
None
|
75 mcg/mL (0.0075% w/v)
|
Topical Solution
|
-
|
MCB Dermatological Products
|
Philippines
|
-
|
06 October 2021
|
06 October 2026
|
| View |
|
DRHR-2060
|
Tretinoin
|
None
|
25 mcg/mL (0.0025% w/v)
|
Topical Solution
|
-
|
MCB Dermatological Products
|
Philippines
|
-
|
06 October 2021
|
06 October 2026
|
| View |
|
DRP-10482
|
Calcium Sennosides
|
Senogen
|
7.5 mg
|
Tablet
|
Laxative
|
Celogen Generics Private Ltd.
|
India
|
Initial
|
01 October 2021
|
01 October 2026
|
| View |
|
DRP-10246
|
Ceftriaxone (As Sodium)
|
Haixone
|
1 g
|
Powder For Injection (I.M./I.V.)
|
Antibacterial (Third-Generation Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
-
|
01 October 2021
|
01 October 2026
|
| View |
DR-XY47359_PI_01.pdf
|
DR-XY47359
|
Salbutamol (as sulfate)
|
Salbo
|
100 mcg
|
Pressurized Metered Dose Inhaler
|
-
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
-
|
01 October 2021
|
01 October 2026
|
| View |
|
DRP-10489
|
Mefenamic Acid
|
None
|
50 mg/5 mL
|
Oral Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
05 October 2021
|
05 October 2026
|
| View |
|
DRP-10500
|
Cefixime (as trihydrate)
|
None
|
100 mg/5 mL
|
Granules for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
06 October 2021
|
06 October 2026
|
| View |
|
DRP-9949
|
Mefenamic Acid
|
None
|
250 mg
|
Film-Coated Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Variation: PCPR Conversion)
|
06 October 2021
|
03 July 2025
|
| View |
|
DRP-9950
|
Mefenamic Acid
|
None
|
500 mg
|
Film-Coated Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
06 October 2021
|
03 July 2025
|
| View |
|
DRP-10437
|
Piperacillin (As Sodium) + Tazobactam (As Sodium)
|
None
|
4 g/500 mg
|
Powder For Injection (I.V)
|
-
|
Aurobindo Pharma Limited (Unit XVI)
|
India
|
-
|
07 October 2021
|
07 October 2026
|
| View |
DRP-10484_PI_01.pdf
|
DRP-10484
|
Meropenem (as trihydrate)
|
MPEN 1000
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Brawn Laboratories Limited
|
India
|
Renewal
|
12 March 2024
|
29 September 2029
|
| View |
|
DRP-5967
|
Irbesartan
|
Irbe
|
300 mg
|
Film-Coated Tablet
|
Angiotensin II Antagonist
|
Jubilant Generics Limited
|
India
|
Automatic Renewal
|
11 January 2022
|
28 January 2027
|
| View |
|
DRP-5977
|
Irbesartan
|
Irbe
|
150 mg
|
Film-Coated Tablet
|
Angiotensin II Antagonist
|
Jubilant Generics Limited
|
India
|
Automatic Renewal
|
11 January 2022
|
28 January 2027
|
| View |
|
DRP-10511
|
Febuxostat
|
Fexogout-80
|
80 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
28 January 2022
|
07 October 2026
|
| View |
|
DRP-10512
|
Febuxostat
|
Fexogout-40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
28 January 2022
|
07 October 2026
|
| View |
|
DRP-10523
|
Multivitamins
|
Multilem
|
Formulation Each capsule contains: Retinol Acetate (Vitamin A)-2500IU Cholecalciferol (Vitamin D3)-400IU Ascorbic Acid (Vitamin C)-80mg Nicotinic Acid-23mg d-Alpha-Tocopheryl Acid Succinate (Vitamin E)-10mg Pyridoxine Hydrochloride (Vitamin B6)-2mg Thiamine Mononitrate (Vitamin B1)-1.7mg Riboflavin (Vitamin B2)-1.3mg Folic Acid-400mcg Cyanocobalamin (Vitamin B12)-6mcg
|
Capsule
|
-
|
Diamond Laboratories Inc.
|
Philippines
|
-
|
08 October 2021
|
08 October 2026
|
| View |
|
DRHR-2061
|
Povidone Iodine
|
None
|
100 mg/mL (10% w/v)
|
Topical Solution
|
-
|
Telstar Manufacturing Corporation
|
Philippines
|
-
|
07 October 2021
|
07 October 2026
|
| View |
|
DRP-10490
|
Lacidipine
|
None
|
6 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
05 October 2021
|
05 October 2026
|
| View |
|
DRP-10492
|
Lacidipine
|
None
|
2 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
05 October 2021
|
05 October 2026
|
| View |
|
DRP-10491
|
Lacidipine
|
None
|
4 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
05 October 2021
|
05 October 2026
|